BrainAurora Medical Technology (HKG:6681) received a Class 2 medical device registration certificate for its cognitive assessment software for patients with depression from Beijing authorities, according to a Tuesday Hong Kong bourse filing.
The software assesses memory, attention, executive function, and information processing speed to help clinicians evaluate patients' cognitive status.
Shares of the firm were up nearly 10% in Wednesday midday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments